Showing 606 news articles about New & experimental HIV treatments

Filters Content type: News Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Rilpivirine proves non-inferior to efavirenz in phase 3 studies

News
20 April 2010
New & experimental HIV treatments

Anti-HIV drugs inhibit emerging virus linked to prostate cancer and chronic fatigue syndrome

News
2 April 2010
New & experimental HIV treatments

Acne drug prevents HIV activation from latently infected cells

News
24 March 2010
New & experimental HIV treatments

South Africa: Delayed drug registrations hard to swallow

News
9 March 2010
New & experimental HIV treatments

New CCR5 antagonist TBR-652 shows good antiviral activity in early study

News
18 February 2010
New & experimental HIV treatments

Elvitegravir 'Quad' pill performs well, new booster cobicistat works as well as ritonavir

News
18 February 2010
New & experimental HIV treatments

CCR5 antagonist vicriviroc fails to surpass potent background regimen

News
18 February 2010
New & experimental HIV treatments

Tesamorelin safe and effective for fat accumulation in patients taking HIV treatment

News
3 February 2010
New & experimental HIV treatments

New heat-stable ritonavir tablet approved in Europe

News
3 February 2010
New & experimental HIV treatments

Merck will not seek vicriviroc licenses in treatment-experienced

News
21 January 2010
The search for a cure

The cure

News
3 December 2009
New & experimental HIV treatments

New hepatitis C protease inhibitors achieve 80% ‘cure’ rate in patients with genotype 1 infection

News
3 November 2009
Starting treatment

FDA committee recommends approval of maraviroc for first-line treatment in US

News
9 October 2009
New & experimental HIV treatments

Maturation inhibitor bevirimat is well tolerated and effective in predicted responders

News
18 September 2009
New & experimental HIV treatments

Dual maintenance therapy with atazanavir plus raltegravir sustains viral suppression

News
18 September 2009
New & experimental HIV treatments

IL-7 may boost CD4 and CD8 T-cells, study shows

News
17 September 2009
New & experimental HIV treatments

GSK's second integrase inhibitor looks potent and well-tolerated in early study

News
17 September 2009
New & experimental HIV treatments

Nutritional formula linked to reduced CD4 cell loss in untreated people

News
17 September 2009
Hepatitis C treatment

Genetic test predicts who will respond to hepatitis C treatment

News
17 August 2009
Infant feeding

Triple-drug treatment during pregnancy reduces risk of nevirapine resistance

News
13 August 2009
Starting treatment

Abacavir as potent as tenofovir for patients starting HIV treatment with a high viral load

News
6 August 2009
New & experimental HIV treatments

Raltegravir moves closer to approval for first-line use in Europe

News
27 July 2009
New & experimental HIV treatments

Once-daily Kaletra as safe and effective as twice-daily dosing

News
22 July 2009
New & experimental HIV treatments

Experimental integrase inhibitor GSK-572 looks good in early studies

News
22 July 2009